The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models
Open accessAbstract
Neuromelanin (NM) accumulates in catecholamine long-lived brain neurons that are lost in neurodegenerative diseases. NM is a complex substance made of melanic, peptide and lipid components. NM formation is a natural protective process since toxic endogenous metabolites are removed during its formation and as it binds excess metals and xenobiotics. However, disturbances of NM synthesis and function could be toxic. Here, we review recent knowledge on NM formation, toxic mechanisms involving NM, go over NM binding substances and suggest experimental models that can help identifying xenobiotic modulators of NM formation or function. Given the high likelihood of a central NM role in age-related human neurodegenerative diseases such as Parkinson’s and Alzheimer’s, resembling such diseases using animal models that do not form NM to a high degree, e.g., mice or rats, may not be optimal. Rather, use of animal models (i.e., sheep and goats) that better resemble human brain aging in terms of NM formation, as well as using human NM forming stem cellbased in vitro (e.g., mid-brain organoids) models can be more suitable. Toxicants could also be identified during chemical synthesis of NM in the test tube.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Scheme 1 The hypothesized biosynthetic pathway of NM is schematically shown to proceed through four main phases. In the initial Phase 1, the oxidation products of DA, or the oxidized DA metabolites [22], generated by catalytic oxidation mediated by Fe3+, or Cu2+, react with fibrillary seeds of aggregated peptides/proteins (blue) at the exposed side chains of Cys, His and Lys forming melanin (orange)-protein conjugates maintaining the fibrillary core as the only structural element. In Phase 2, the undegradable conjugates are engulfed by the phagophore and isolated from the cytosol through a double lipid membrane (yellow). The autophagic vacuoles fuse with lysosomes (blue circle) in Phase 3, causing interaction between the melanin-protein conjugates with other proteins, enzymes and lipids carried by lysosomes, and are transformed into autolysosomes. The resulting autolysosomes fuses with other vesicles containing lipids that attach to melanin-protein conjugates to form NM. Finally, in Phase 4 these organelles fuse with other autophagic vacuoles containing NM precursors or with mature NM organelles. A more detailed description of the entire process can be found in Zucca et al., 2018 [14].](https://figures.cochat.ai/paper-figures/b8ee9e299bc442cda619b3404ba5faf4/interaction-of-neuromelanin-with-xenobiotics-and-consequences-for-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neuromelanin is sparse or absent in lower animals (229, 233–235), which do not contract sporadic PD (236).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [236]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 2×
“To clarify these mechanisms, expression of MHC-I was induced in cultured neurons by exposure to factors commonly released by microglia activated by NM or α-synuclein, known microglia activators [36] and both present extracellularly in PD brains, or in condition of high oxidative stress derived by high cytosolic DA.”
BackgroundSelf-citationMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 1×
“A typical neuropathological feature of PD is the presence of extracellular NM in the degenerating SN tissue [31], due to the conspicuous and selective death of pigmented dopaminergic neurons over the disease [32].”
BackgroundDexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
The physical and chemical properties of eumelanin
Meredith, P., & Sarna, T. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00345.x · Cited by 1,033
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., et al. (2017) · Science · doi:10.1126/science.aam9080 · Cited by 874
Jo, J., Xiao, Y., Sun, A. X., Cukuroglu, E., Tran, H.-D., Göke, J., Tan, Z. Y., Saw, T. Y., Tan, C.-P., Lokman, H., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.07.005 · Cited by 861
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 1×
“Notably, in SN of PD patients and those with Parkinsonian syndromes numerous activated microglia cells have been observed in close proximity of degenerating neurons and free NM debris [33,34] which were also observed inside reactive microglia [31].”
BackgroundOxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Cited by
Kabir, M. T., Rahman, M. H., Shah, M., Jamiruddin, M. R., Basak, D., Al-Harrasi, A., Bhatia, S., Ashraf, G. M., Najda, A., El-kott, A. F., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112610 · Cited by 181
Cerebral Iron Deposition in Neurodegeneration
Dusek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. O. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159
Self-citationWise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D., Zecca, L., & Burbulla, L. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105920 · Cited by 99
Self-citationSun, J., Lin, X., Lu, D.-H., Wang, M., Li, K., Li, S., Li, Z., Zhu, C., Zhang, Z.-M., Yan, C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165228 · Cited by 95
Zucca, F. A., Capucciati, A., Bellei, C., Sarna, M., Sarna, T., Monzani, E., Casella, L., & Zecca, L. (2023) · IUBMB Life · doi:10.1002/iub.2654 · Cited by 69
“In addition, due to its poor solubility, NM could remain for long time in the extracellular milieu of SN sustaining this chronic inflammatory process that can be exacerbated also by release of toxic compounds and redox active metals immobilized into NM structure.(57,58) Synthetic melanins have been used to induce and…”
BackgroundSelf-citation
Metadata
- Authors
- Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T.
- Affiliations
- University of Pavia (IT)
- Institute of Biomedical Technologies (IT)
- Norwegian Institute of Public Health (NO)
- Corresponding author
- Hofer, Tim
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-05-21
- Volume
- 10
- Issue
- 6
- Pages
- 824
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC8224073
- OpenAlex
- W3165207429
- Cited by
- 36
- References
- 143
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 4 · 2023: 12 · 2022: 6 · 2021: 1
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (2015T778JW)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- neuromelanin, xenobiotics, neurodegeneration, catecholaminergic neurons, metal ion binding, neurotoxicity, Parkinson's disease, Alzheimer's disease, brain aging, toxicant identification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models. https://app.cochat.ai/papers/10.3390/antiox10060824
- The paper
- Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T. (2021). Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models. Antioxidants. https://doi.org/10.3390/antiox10060824
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.